Sakai Y, Kubo K, Matsumoto K, Hosono M, Monzen H
In Vivo. 2025; 39(2):894-901.
PMID: 40010996
PMC: 11884445.
DOI: 10.21873/invivo.13893.
Fager M, Gubanski M, Carlsson Tedgren A, Benmakhlouf H
Acta Oncol. 2025; 64:319-325.
PMID: 40008908
PMC: 11884334.
DOI: 10.2340/1651-226X.2025.41924.
Vellini L, Quaranta F, Menna S, Pilloni E, Catucci F, Lenkowicz J
Phys Imaging Radiat Oncol. 2025; 33:100708.
PMID: 39958708
PMC: 11830347.
DOI: 10.1016/j.phro.2025.100708.
Kang S, Park J, Choi G, Kim J, Park J, Kim H
PLoS One. 2025; 20(1):e0313438.
PMID: 39752480
PMC: 11698420.
DOI: 10.1371/journal.pone.0313438.
Huang Y, Yang J, Song R, Qin T, Yang M, Liu Y
Front Oncol. 2024; 14:1431082.
PMID: 39703844
PMC: 11655335.
DOI: 10.3389/fonc.2024.1431082.
Radiotherapy & total neoadjuvant therapy for recurrent rectal cancer in previously irradiated patients, (RETRY): a multicenter prospective observational study.
Gambacorta M, Romano A, Caravatta L, Macchia G, Chiloiro G, Galofaro E
Radiat Oncol. 2024; 19(1):174.
PMID: 39695675
PMC: 11653832.
DOI: 10.1186/s13014-024-02555-x.
Re-irradiation for recurrent glioblastoma: a pattern of care analysis.
Rogers S, Gross M, Ermis E, Cosgun G, Baumert B, Mader T
BMC Neurol. 2024; 24(1):462.
PMID: 39587462
PMC: 11590342.
DOI: 10.1186/s12883-024-03954-z.
Impact of motion management strategies on abdominal organ at risk delineation for magnetic resonance-guided radiotherapy.
Daly M, McDaid L, Anandadas C, Brocklehurst A, Choudhury A, McWilliam A
Phys Imaging Radiat Oncol. 2024; 32:100650.
PMID: 39381613
PMC: 11459006.
DOI: 10.1016/j.phro.2024.100650.
Insights into the dosimetric and geometric characteristics of stereotactic radiosurgery for multiple brain metastases: A systematic review.
Mukwada G, Chamunyonga C, Rowshanfarzad P, Gill S, Ebert M
PLoS One. 2024; 19(8):e0307088.
PMID: 39121064
PMC: 11315342.
DOI: 10.1371/journal.pone.0307088.
Comparison of stereotactic radiotherapy and protons for uveal melanoma patients.
Fleury E, Pignol J, Kilic E, Milder M, van Rij C, Naus N
Phys Imaging Radiat Oncol. 2024; 31:100605.
PMID: 39050744
PMC: 11268348.
DOI: 10.1016/j.phro.2024.100605.
Dose prescription for stereotactic body radiotherapy: general and organ-specific consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery.
Brunner T, Boda-Heggemann J, Burgy D, Corradini S, Dieckmann U, Gawish A
Strahlenther Onkol. 2024; 200(9):737-750.
PMID: 38997440
PMC: 11343978.
DOI: 10.1007/s00066-024-02254-2.
Utilizing collimated aperture with proton pencil beam scanning (PBS) for stereotactic radiotherapy.
Chou C, Tsai T, Huang H, Wang C, Lee S, Hsu S
J Appl Clin Med Phys. 2024; 25(7):e14362.
PMID: 38669175
PMC: 11244669.
DOI: 10.1002/acm2.14362.
Investigation of the risk factors in the development of radionecrosis in patients with brain metastases undergoing stereotactic radiotherapy.
Dogan B, Demir H, Isik N, Gunalp G, Gunbey H, Yaprak G
Br J Radiol. 2024; 97(1157):1022-1028.
PMID: 38426391
PMC: 11075992.
DOI: 10.1093/bjr/tqae051.
Automated planning of stereotactic spine re-irradiation using cumulative dose limits.
Meyer S, Zhang L, Liu Y, Kuo L, Hu Y, Yamada Y
Phys Imaging Radiat Oncol. 2024; 29:100547.
PMID: 38390589
PMC: 10881437.
DOI: 10.1016/j.phro.2024.100547.
Optimizing Clinical Implementation of Hypofractionation: Comprehensive Evidence Synthesis and Practical Guidelines for Low- and Middle-Income Settings.
Starling M, Thibodeau S, de Sousa C, Restini F, Viani G, Gouveia A
Cancers (Basel). 2024; 16(3).
PMID: 38339290
PMC: 10854666.
DOI: 10.3390/cancers16030539.
Historical Progress of Stereotactic Radiation Surgery.
Khaledi N, Khan R, Grafe J
J Med Phys. 2024; 48(4):312-327.
PMID: 38223793
PMC: 10783188.
DOI: 10.4103/jmp.jmp_62_23.
Dosimetric impact of CT metal artifact reduction for spinal implants in stereotactic body radiotherapy planning.
Li B, Huang J, Ruan J, Peng Q, Huang S, Li Y
Quant Imaging Med Surg. 2023; 13(12):8290-8302.
PMID: 38106297
PMC: 10721987.
DOI: 10.21037/qims-23-442.
Feasibility of fast, four-dimensional computed tomography-based O-ring LINAC plans for lung stereotactic body radiotherapy in patients with poor performance status.
Heo E, Kim M, Park C, Chang K, Kim K, Shim J
Front Oncol. 2023; 13:1270677.
PMID: 38074663
PMC: 10699148.
DOI: 10.3389/fonc.2023.1270677.
Stereotactic radiotherapy in the management of oligometastatic and recurrent head and neck cancer: a single-center experience.
Mohamed A, Goncalves M, Singh B, Tometten M, Rashad A, Holzle F
Strahlenther Onkol. 2023; 200(5):400-408.
PMID: 38063900
PMC: 11039526.
DOI: 10.1007/s00066-023-02180-9.
Cochlear-optimized treatment planning in photon and proton radiosurgery for vestibular schwannoma patients.
Koetsier K, Oud M, de Klerck E, Hensen E, van Vulpen M, van Linge A
Clin Transl Radiat Oncol. 2023; 43:100689.
PMID: 37867612
PMC: 10585330.
DOI: 10.1016/j.ctro.2023.100689.